Pascale Fouqueray Selected Research

Pascale Fouqueray Research Topics

16	Type 2 Diabetes Mellitus (MODY) 10/2023 - 03/2013
4	Non-alcoholic Fatty Liver Disease 01/2023 - 08/2021
4	Insulin Resistance 11/2022 - 01/2016
3	Inflammation (Inflammations) 01/2022 - 08/2021
2	Alcoholic Fatty Liver 01/2023 - 11/2021
2	Fibrosis (Cirrhosis) 01/2023 - 08/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2021
1	Hyperlactatemia 01/2022
1	Lactic Acidosis 01/2022
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Overweight 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Fatty Liver 12/2021
1	Edema (Dropsy) 08/2021
1	Weight Gain 08/2021

17	imegliminIBA 10/2023 - 03/2013
10	Hypoglycemic Agents (Hypoglycemics)IBA 10/2023 - 03/2013
3	2- chloro- 3- (1- hydroxy- 5,6,7,8- tetrahydronaphthalen- 2- yl)- 6- oxo- 5- phenyl- 7H- thieno)(2,3- b)pyridin- 4- olate potassiumIBA 01/2022 - 11/2021
3	Adenylate KinaseIBA 01/2022 - 11/2021
2	Pioglitazone (Actos)FDA Link 01/2023 - 08/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2013
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2023
1	nasIBA 01/2023
1	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 01/2022
1	BiguanidesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Monocarboxylic Acid TransportersIBA 08/2021
1	DeuteriumIBA 08/2021
1	CholesterolIBA 08/2021
1	PPAR gammaIBA 08/2021
1	Triglycerides (Triacylglycerol)IBA 08/2021
1	Nonesterified Fatty Acids (NEFA)IBA 08/2021
1	ElementsIBA 01/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 07/2014

6	Therapeutics 01/2022 - 03/2013
2	Glycemic Control 10/2020 - 03/2013